Patents by Inventor Roger WIEGAND

Roger WIEGAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS
    Publication number: 20170325457
    Abstract: The present disclosure is directed to formulations comprising (1) at least one formulation transport agent, (2) at least one complexing agent, and (3) at least one active agent that modulates one or more traits of a target insect, plant, or plant pathogen. The present disclosure is also directed to methods of delivering such formulations to the target organism, as well as to formulation transport agents used to prepare such formulations.
    Type: Application
    Filed: April 26, 2017
    Publication date: November 16, 2017
    Applicant: Preceres Inc.
    Inventors: Richard Wayne Heidebrecht, JR., Sonke Svenson, Roger Wiegand, Jungyeon Hwang, Jen Beaudoin, Cheng Zhong
  • 2-aminoindole compounds and methods for the treatment of malaria
    Patent number: 8980926
    Abstract: The present invention relates to methods of treating a subject with malaria comprising administering a 2-aminoindole compound represented by Formula: (I)—The values and preferred values of the variables in Structural Formula I are defined herein.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: March 17, 2015
    Assignees: Genzyme Corporation, President and Fellows of Harvard College, Massachusetts Institute of Technology
    Inventors: Ralph Mazitschek, Jon C. Clardy, Dyann Wirth, Roger Wiegand, Sameer Urgaonkar, Mary Lynn Baniecki, Joseph Cortese, Cassandra Celatka, Yibin Xiang, Renato Skerlj, Elyse M. J. Bourque
  • 2-Aminoindole Compounds And Methods For The Treatment Of Malaria
    Publication number: 20120232063
    Abstract: The present invention relates to methods of treating a subject with malaria comprising administering a 2-aminoindole compound represented by Formula: (I)—The values and preferred values of the variables in Structural Formula I are defined herein.
    Type: Application
    Filed: October 28, 2010
    Publication date: September 13, 2012
    Inventors: Ralph Mazitschek, Jon C. Clardy, Dyann Wirth, Roger Wiegand, Sameer Urgaonkar, Mary Lynn Baniecki, Joseph Cortese, Cassandra Celatka, Yibin Xiang, Renato Skerlj, Elyse M.J. Bourque
  • Arabidopsis thaliana Genome Sequence and Uses Thereof
    Publication number: 20110014706
    Abstract: The present invention relates to nucleic acid sequences from the dicotyldonus plant Arabidopsis thaliana and, in particular, to genomic DNA sequences. The invention encompasses nucleic acid molecules present in non-coding regions as well as nucleic acid molecules that encode proteins and fragments of proteins. In addition, proteins and fragments of proteins so encoded and antibodies capable of binding the proteins are encompassed by the present invention. The invention also encompasses oligonucleotides including primers, e.g. useful for amplifying nucleic acid molecules, and collections of nucleic acid molecules and oligonucleotides, e.g. in microarrays. The invention also provides constructs and transgenic cells and organisms comprising nucleic acid molecules of the invention.
    Type: Application
    Filed: December 28, 1999
    Publication date: January 20, 2011
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Yongwei CAO, David KOVALIC, Jingdong LIU, James MCININCH, Steven ROUNSLEY, Sai SUBRAMANIAM, Roger WIEGAND
  • Arabidopsis thaliana Genome Sequence and Uses Thereof
    Publication number: 20100255584
    Abstract: The present invention relates to nucleic acid sequences from the dicotyldonus plant Arabidopsis thaliana and, in particular, to genomic DNA sequences. The invention encompasses nucleic acid molecules present in non-coding regions as well as nucleic acid molecules that encode proteins and fragments of proteins. In addition, proteins and fragments of proteins so encoded and antibodies capable of binding the proteins are encompassed by the present invention. The invention also encompasses oligonucleotides including primers, e.g. useful for amplifying nucleic acid molecules, and collections of nucleic acid molecules and oligonucleotides, e.g. in microarrays. The invention also provides constructs and transgenic cells and organisms comprising nucleic acid molecules of the invention.
    Type: Application
    Filed: December 28, 1999
    Publication date: October 7, 2010
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Cao YONGWEI, David KOVALIC, Jingdong LIU, James MCININCH, Steven ROUNSLEY, Sai SUBRAMANIAM, Roger WIEGAND